Novo Nordisk (NOVO B) DKK0.1 B
Sell:779.20 DKKBuy:779.50 DKK
2.30 DKK
(0.29%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:779.20 DKK
Buy:779.50 DKK
Change:2.30 DKK
(0.29%)
2.30 DKK
(0.29%)Prices delayed by at least 15 minutes
Sell:779.20 DKK
Buy:779.50 DKK
Change:2.30 DKK
(0.29%)
2.30 DKK
(0.29%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 November 2024 | David S (Dave) MooreExecutive Vice President | Buy Regular purchase transaction | 2,500 | 709.25 DKK | 1,773,118.70 DKK | 0 |
| 12 November 2024 | Choi Lai (Christina) LawIndependent Director | Buy Regular purchase transaction | 1,300 | 743.31 DKK | 966,301.02 DKK | 6,000 |
| 11 November 2024 | David S (Dave) MooreExecutive Vice President | Sell Tax related | 9,919 | 759.96 DKK | 7,538,047.37 DKK | 0 |
| 8 November 2024 | NOVO HOLDINGS ASParent Company | Sell Regular sell transaction (market) | 6,311,250 | 750.42 DKK | 4,736,088,225.00 DKK | 177,560,500 |
| 6 November 2024 | Choi Lai (Christina) LawIndependent Director | Buy Regular purchase transaction | 1,400 | 753.02 DKK | 1,054,226.88 DKK | 4,700 |
| 28 August 2024 | Douglas (Doug) LangaHead of Division | Buy Regular purchase transaction | 4 | 904.35 DKK | 3,617.40 DKK | 0 |
| 28 August 2024 | Douglas (Doug) LangaHead of Division | Buy Regular purchase transaction | 13 | 904.41 DKK | 11,757.33 DKK | 0 |
| 19 August 2024 | Sylvie Louise GrégoireIndependent Director | Buy Regular purchase transaction | 1 | 912.75 DKK | 912.75 DKK | 0 |
| 19 August 2024 | Sylvie Louise GrégoireIndependent Director | Buy Regular purchase transaction | 200 | 913.05 DKK | 182,610.00 DKK | 0 |
| 19 August 2024 | Sylvie Louise GrégoireIndependent Director | Buy Regular purchase transaction | 2 | 913.15 DKK | 1,826.30 DKK | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 6 May 2024 | NOVO HOLDINGS ASParent Company | Sell Regular sell transaction (market) | 6,311,250 | 860.02 DKK | 5,427,801,225.00 DKK | 183,871,750 |
| 8 November 2024 | NOVO HOLDINGS ASParent Company | Sell Regular sell transaction (market) | 6,311,250 | 750.42 DKK | 4,736,088,225.00 DKK | 177,560,500 |
| 5 February 2024 | Lars Fruergaard JoergensenPresident/CEO | Sell Option/Award related | 129,916 | 809.76 DKK | 105,200,780.16 DKK | 327,435 |
| 5 February 2024 | Camilla SylvestExecutive Board | Sell Option/Award related | 74,915 | 809.71 DKK | 60,659,424.65 DKK | 21,072 |
| 6 February 2024 | Henrik Ehlers WulffExecutive Board | Sell Option/Award related | 60,000 | 823.09 DKK | 49,385,400.00 DKK | 90,419 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.